A subpopulation of CD103posICOSpos Treg cells occurs at high frequency in lymphopenic mice and represents a lymph node specific differentiation stage

European Journal of Immunology

Volumn 45, Issue 6, 2015, Pages 1760-1771

  Barthlott, Thomas ^a   Bosch, Angela J T ^a   Berkemeier, Caroline ^a   Nogales Cadenas, Rubén ^b,d   Jeker, Lukas T ^a,e   Keller, Marcel P ^a,f   Pascual Montano, Alberto ^b   Holländer, Georg A ^a,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Actelion Pharmaceuticals   (Switzerland)

Author keywords

CD103; ICOS; IL 7; LN Lymphopenia; Treg cell

Indexed keywords

CD103 ANTIGEN; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 2; SMAD4 PROTEIN; TRANSCRIPTION FACTOR FOXP3; ALPHA E INTEGRINS; ALPHA INTEGRIN; CYTOKINE; INTERLEUKIN 7; LEUKOCYTE ANTIGEN; THYMIC STROMAL LYMPHOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; MICROENVIRONMENT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; ANIMAL; BLOOD; CELL DIFFERENTIATION; CLUSTER ANALYSIS; CYTOLOGY; GENE EXPRESSION PROFILING; HOMEOSTASIS; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELLULAR MICROENVIRONMENT; CLUSTER ANALYSIS; CYTOKINES; GENE EXPRESSION PROFILING; HOMEOSTASIS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTEGRIN ALPHA CHAINS; INTERLEUKIN-7; LYMPH NODES; LYMPHOCYTE COUNT; LYMPHOPENIA; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84930416253     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445235     Document Type: Article

References (65)

1. Josefowicz, S. Z., Lu, L. F. and Rudensky, A. Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012. 30: 531-564.
2. Chen, X. and Oppenheim, J. J., Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. Int. Immunopharmacol. 2011. 11: 1489-1496.
3. Campbell, D. J., and Koch, M. A., Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 2011. 11: 119-130.
4. Lehmann, J., Huehn, J., dela Rosa, M., Maszyna, F., Kretschmer, U., Krenn, V., Brunner, M. et al., Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA 2002. 99: 13031-13036.
5. Banz, A., Peixoto, A., Pontoux, C., Cordier, C., Rocha, B. and Papiernik, M., A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis. Eur. J. Immunol. 2003. 33: 2419-2428.
6. Ermann, J., Hoffmann, P., Edinger, M., Dutt, S., Blankenberg, F. G., Higgins, J. P., Negrin, R. S. et al., Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005. 105: 2220-2226.
7. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B. and Campbell, D. J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 2009. 10: 595-602.
8. Zheng, Y.1, Chaudhry, A., Kas, A., deRoos, P., Kim, J. M., Chu, T. T., Corcoran, L. et al., Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 2009. 458: 351-356.
9. Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A. and Rudensky, A. Y., CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 2009. 326: 986-991.
10. D'Cruz, L. M. and Klein, L., Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 2005. 6: 1152-1159.
11. Fontenot, J. D., Rasmussen, J.P., Gavin, M. A. and Rudensky, A. Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 2005. 6: 1142-1151.
12. Yu, A., Zhu, L., Altman, N. H. and Malek, T. R., A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity. 2009. 30: 204-217.
13. Zhang, H., Chua, K. S., Guimond, M., Kapoor, V., Brown, M. V., Fleisher, T. A., Long, L. M. et al., Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med. 2005. 11: 1238-1243.
14. LeCampion, A., Pommier, A., Delpoux, A., Stouvenel, L., Auffray, C., Martin, B. and Lucas, B., IL-2 and IL-7 determine the homeostatic balance between the regulatory and conventional CD4+ T cell compartments during peripheral T cell reconstitution. J. Immunol. 2012. 189: 3339-3346.
15. Bosco, N., Agenes, F., Rolink A. G. and Ceredig, R., Peripheral T cell lymphopenia and concomitant enrichment in naturally arising regulatory T cells: the case of the pre-Talpha gene-deleted mouse. J. Immunol. 2006. 177: 5014-5023.
16. Chen, X., Priatel, J. J., Chow, M. T. and Teh, H. S., Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J. Immunol. 2008. 180: 5973-5982.
17. Lages, C. S., Suffia, I., Velilla, P. A., Huang, B., Warshaw, G., Hildeman, D. A., Belkaid, Y. et al., Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J. Immunol. 2008. 181: 1835-1848.
18. + regulatory T cells. J. Immunol. 2003. 171: 5678-5682.
19. + T cell receptors. Immunity. 2004. 21: 267-277.
20. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. and Rudensky, A. Y., Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat. Immunol. 2001. 3: 33-41.
21. Jeker, L. T., Barthlott, T., Keller M. P., Zuklys, S., Hauri-Hohl, M., Deng, C. X. and Holländer, G. A., Maintenance of a normal thymic microenvironment and T-cell homeostasis require Smad4-mediated signaling in thymic epithelial cells. Blood 2008. 112: 3688-3695.
22. Fehling, H. J., Krotkova, A., Saint-Ruf, C. and vonBoehmer, H., Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature 1995. 375: 795-798.
23. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R., T cell receptor antagonist peptides induce positive selection. Cell 1994. 76: 17-27.
24. Wan, Y. Y. and Flavell, R. A., Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007. 445: 766-770.
25. Chauhan, S. K., Saban, D. R., Lee, H. K. and Dana, R., Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J. Immunol. 2009. 182: 148-153.
26. Brownlie, R. J., Miosge, L.A., Vassilakos, D., Svensson, L. M., Cope, A. and Zamoyska, R., Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci. Signal. 2012. 5: ra87. DOI:10.1126/scisignal.2003365.
27. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari Z., Nomura, T. et al., CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008. 322: 271-275.
28. Polanczyk, M. J., Hopke, C., Vandenbark, A. A. and Offner, H., Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol. 2007. 13: 337-343.
29. Fisson, S., Darrasse-Jèze, G., Litvinova, E., Septier, F., Klatzmann, D., Liblau, R. and Salomon, B. L., Continuous activation of autoreactive CD4+ CD25+ regulatory T Cells in the steady state. J. Exp. Med. 2003. 198: 737-746.
30. Smigiel, K. S., Richards, E., Srivastava, S, Thomas, K. R., Dudda, J. C., Klonowski, K. D. and Campbell, D. J., CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 2014. 211: 121-136.
31. Wei, S., Kryczek, I. and Zou, W., Regulatory T-cell compartmentalization and trafficking. Blood 2006. 108: 426-431.
32. Menning, A., Höpken, U. E., Siegmund, K., Lipp, M., Hamann, A. and Huehn, J., Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur. J. Immunol. 2007. 37: 1575-1583.
33. Schneider, M. A., Meingassner, J. G., Lipp, M., Moore H. D. and Rot, A., CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J. Exp. Med. 2007. 204: 735-745.
34. Shevach, E. M., Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009. 30: 636-645.
35. Vignali, D. A., Collison, L. W. and Workman, C. J., How regulatory T cells work. Nat. Rev. Immunol. 2008. 8: 523-532.
36. Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G. T. et al., The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011. 12: 304-311.
37. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert B. L., Gillette, M. A., Paulovich, A. et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005. 102: 15545-15550.
38. Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., Mathis, D. and Benoist, C., Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007. 27: 786-800.
39. Huehn, J., Siegmund, K., Lehmann, J. C., Siewert, C., Haubold, U., Feuerer, M., Debes, G. F. et al., Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 2004. 199: 303-313.
40. McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M. and Byrne, M. C., CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002. 16: 311-323.
41. Stephens, G. L., Andersson, J., and Shevach, E. M., Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 2007 178: 6901-6911.
42. Feuerer, M., Hill, J. A., Kretschmer, K., vonBoehmer, H., Mathis, D. and Benoist, C., Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. USA 2010. 107: 5919-5924.
43. Cheng, G., Yuan, X., Tsai, M.S., Podack, E. R., Yu, A. and Malek, T. R., IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J. Immunol. 2012. 189: 1780-1791.
44. Swee, L. K., Nusser, A., Curti, M., Kreuzaler, M., Rolink, H., Terracciano, L., Melchers, F. et al., The amount of self-antigen determines the effector function of murine T cells escaping negative selection Eur. J. Immunol. 2014. 44: 1299-1312.
45. Fry, T. J. and Mackall, C. L., The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 2005. 174: 6571-6576.
46. Simonetta, F., Chiali, A., Cordier, C., Urrutia, A., Girault, I., Bloquet, S., Tanchot, C. et al., Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur. J. Immunol. 2010. 40: 2528-2538.
47. vonFreeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E. and Murray, R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 1995. 181: 1519-1526.
48. Al-Shami, A., Spolski, R., Kelly, J., Fry, T., Schwartzberg, P.L., Pandey, A., Mackall, C. L. et al., A role for thymic stromal lymphopoietin in CD4+ T cell development. J. Exp. Med. 2004. 200: 159-168.
49. Mertsching, E., Burdet, C. and Ceredig, R., IL-7 transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int. Immunol. 1995. 7: 401-414.
50. Annacker, O., Coombes, J. L., Malmstrom, V., Uhlig, H. H., Bourne, T., Johansson-Lindbom, B., Agace, W. W. et al., Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 2005. 202: 1051-1061.
51. Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G. et al., Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002. 8: 1024-1032.
52. Herman, A. E., Freeman, G. J., Mathis, D. and Benoist, C., CD4+ CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 2004. 199: 1479-1489.
53. Burmeister, Y., Lischke, T., Dahler, A.C., Mahles, W. W., Lam, K. P., Coyle, A. J., Kroczek, R. A. et al., ICOS controls the pool size of effector-memory and regulatory T cells. J. Immunol. 2008. 180: 774-782.
54. Kornete, M., Sgouroudis, E., and Piccirillo, C.A., ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J. Immunol. 2012. 188: 1064-1074.
55. Redpath, S. A., vander Werf, N., Cervera, A. M., MacDonald, A. S., Gray, D., Maizels, R. M. and Taylor, M. D., ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur. J. Immunol. 2013. 43: 705-715.
56. Ito, T., Hanabuchi, S., Wang, Y. H., Park, W. R., Arima, K., Bover, L., Qin, F. X. F. et al., Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery. Immunity 2008. 28: 870-880.
57. Strauss, L., Bergmann, C., Szczepanski, M. J., Lang, S., Kirkwood, J. M. and Whiteside, T. L., Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications impact on tumor-mediated immune suppression. J Immunol. 2008. 180: 2967-2980.
58. Sim, G. C., Martin-Orozco, N., Jin, L., Yang, Y., Wu, S., Washington, E., Sanders, D. et al., IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients. J. Clin. Invest. 2014. 124: 99-110.
59. Simonetta, F., Gestermann, N., Martinet, K. Z., Boniotto, M., Tissières, P., Seddon, B. and Bourgeois, C., Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis. PLoS One 2012. 7: e36596. DOI:10.1371/journal.pone.0036596.
60. Peffault de Latour, R., Dujardin, H. C., Mishellany, F., Burlen-Defranoux, O., Zuber, J., Marques, R., Di Santo, J. et al., Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. Blood 2006. 108: 2300-2306.
61. Kim, G. Y., Ligons, D. L., Hong, C., Luckey, M. A., Keller, H. R., Tai, X., Lucas, P. J. et al., An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J. Immunol. 2012. 188: 5859-5866.
62. Mazzucchelli, R., Hixon, J. A., Spolski, R., Chen, X., Li, W. Q., Hall, V. L., Willette-Brown, J. et al., Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood 2008. 112: 3283-3292.
63. Suffner, J., Hochweller, K., Kühnle, M.-C., Li, X., Kroczek, R. A., Garbi, N. and Hämmerling, G. J., Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3. LuciDTR mice. J. Immunol. 2010. 184: 1810-1820.
64. Krupica, T., Jr., Fry, T. J. and Mackall, C. L., Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 2006. 120: 121-128.
65. Segura, E. and Villadogas, J. A., Antigen presentation by dendritic cells in vivo. Curr. Opin. Immunol. 2009. 21: 105-110.